01:27 , Sep 20, 2014 |  BC Extra  |  Financial News

Exagen files for IPO

Exagen Diagnostics Inc. (Vista, Calif.) filed to raise up to $69 million in an IPO on NASDAQ underwritten by Leerink; Baird; and William Blair. Exagen markets four products to diagnose rheumatic diseases. Its lead product,...
08:00 , Jan 16, 2012 |  BC Week In Review  |  Company News

Exagen sales and marketing update

Exagen launched Avise SLE as an aid in diagnosing systemic lupus erythematosus (SLE). Avise SLE is a panel of five serum biomarkers for the differential diagnosis of SLE and rheumatic diseases. Exagen Diagnostics Inc., Albuquerque,...